Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
J&J Makes Big Bet on Rare Disease With $30 Billion Actelion Deal - Bloomberg
Big Boss - Jean-Paul Clozel, CEO Idorsia - Play RTS
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Actelion Story - Profile, History, Founder, CEO | Famous Pharmaceutical Companies | SuccessStory
Swiss biotech Actelion CEO Jean-Paul Clozel endorses independence not acquisition - CEOWORLD magazine
Was plant das Ehepaar Clozel? | NZZ
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
Actelion Could Boost Takeover Price for Johnson & Johnson
European pharma: CEO talent is the new measure of company calibre
Jean-Paul Clozel
Johnson & Johnson pays big for Swiss biotech firm Actelion | Euronews
Actelion - Wikipedia
How is Actelion Spin-Off Idorsia Doing One Year Later?
Jean-Paul Clozel | EY - Global
Idorsia, a small company with a big portfolio says Martine Clozel
Medical couple and butcher's boy win big from Actelion sale | Reuters
Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
Jean-Paul Clozel
Startup Guide on Twitter: "Jean-Paul and Martine Clozel are experienced founders and leading figures in the Basel Area. After Actelion, the first company they cofounded, was acquired by Johnson & Johnson, they
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
